SEC Form 4 · accession 0001213900-17-013250
FENNEC PHARMACEUTICALS INC. · FENC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Essetifin SPA
10% Owner
Paolo Cavazza
10% Owner
Francesca Cavazza
10% Owner
Silvia Cavazza
10% Owner
Enrico Cavazza
10% Owner
Preta Martina Cavazza
10% Owner
Period of report
Dec 12, 2017
Accepted (ET)
Dec 14, 2017 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001211583
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 12, 2017 | P | 294,115 | $8.50 | A | 3,225,694 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Such shares were purchased in connection with a public offering by the issuer under a shelf registration statement, which closed on December 12, 2017.
- F2Dispositive power over the shares of common stock owned by Essetifin S.p.A. is shared by Enrico Cavazza, Silvia Cavazza, Francesca Cavazza, Martina Cavazza Preta and Paolo Cavazza. Each of Enrico Cavazza, Silvia Cavazza, Francesca Cavazza, Martina Cavazza Preta and Paolo Cavazza disclaims beneficial ownership of all shares of common stock held by Essetifin S.p.A. except to the extent of any pecuniary interest therein.